Missling Christopher U

President and CEO, DirectorANAVEX LIFE SCIENCES CORP. (AVXL) · full profile →Form 4 · filed Jul 1, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2021Sell(S)52K$26.00$1.3M1.0M
Jun 29, 2021Option exercise(M)52K$1.32$68K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2021Option exercise(M)52K$073K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-21-001127) within minutes of acceptance. Every field above traces to the original document. Verify it directly: